| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698995 | Clinical Oncology | 2010 | 10 Pages |
Abstract
Whole-body FDG-PET allows frequent heterogeneous responses after systemic therapy to be identified in bone-dominant metastatic breast cancer patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
V. Huyge, C. Garcia, J. Alexiou, L. Ameye, B. Vanderlinden, M. Lemort, P. Bergmann, A. Awada, J.-J. Body, P. Flamen,